Press Releases
Biovista expands Project Prodigy collaborations in personalized medicine
Biovista announced that it is collaborating with HPE to advance Biovista’s Project Prodigy Big Data AI healthcare platform applied in the personalized medicine vertical. ...
Drug Research
InDex Pharmaceuticals receives orphan-drug designation for pediatric ulcerative colitis in the US
InDex Pharmaceuticals Holding AB announced that the US FDA has granted orphan-drug designation for the drug candidate cobitolimod for treatment of ulcerative colitis in pediatric...
Clinical Trials
Randomization In Phase 2/3 Trial In Spinocerebellar Ataxia Completed By Biohaven
Biohaven Pharmaceutical Holding Company Ltd. announced today that it has commenced dosing of all 141 randomized patients with spinocerebellar ataxia (SCA)...
Clinical Trials
Phase III Study Of Viaskin Peanut – Allergic Of Patients One To Three Years Of Age Initiated By DBV Technologies
DBV Technologies announced that the first patient has been enrolled in EPITOPE ( EPIT in TO ddlers with PE anut Allergy), a global,...
Press Releases
Clinerion’s Patient Recruitment System Platform Joined By Baskent University
Başkent University’s hospital cluster is joining the Patient Recruitment System platform, giving their 4.5 M patients access to innovative treatments and therapies offered by...
Industry Reports
TraceLink expands offering with ROC IT Solutions acquisition
TraceLink Inc., the world’s largest track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient...
News
KALYDECO® ( ivacaftor ) Approved By FDA For More Than 600 People Ages 2 And Older With Cystic Fibrosis Who Have Certain Residual Function...
Vertex Pharmaceuticals Incorporated announced that the U.S. FDA has approved KALYDECO® (ivacaftor) for use in more than 600 people with CF ages 2 and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read